A PHASE 2a, RANDOMIZED, OBSERVER-BLIND, PLACEBO-CONTROLLED, DOSE-CONFIRMATION STUDY TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF MRNA-1273 SARS-COV-2 VACCINE IN ADULTS AGED 18 YEARS A
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
May 1, 2021
End Date
June 30, 2022
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
May 1, 2021
End Date
June 30, 2022